The incidence and prevalence of reported multiple sclerosis

Annals of Neurology
H M Baum, B B Rothschild

Abstract

A national survey, sponsored by the National Institute of Neurological and Communicative Disorders and Stroke, to determine the incidence, prevalence, and economic impact of multiple sclerosis has just been completed. These data are the first report of the results. Based on the data gathered, it is estimated that on January 1, 1976, there were a reported 123,000 multiple sclerosis patients in the conterminous United States (a rate of 58 per 100,000). The annual incidence for the period 1970-1975 was estimated to be 8,800 (a rate of 4.2 per 100,000). The pattern of the disease being more common among females, whites, persons aged 30-50 years, and individuals living above the 37th parallel was also demonstrated. In addition to demographic characteristics, selected disease characteristics of the incidence and prevalence populations were also examined.

References

Feb 1, 1975·Acta Neurologica Scandinavica·J F Kurtzke
Dec 1, 1970·American Journal of Public Health and the Nation's Health·R RayF L Drew
Aug 1, 1971·Archives of Neurology·A K PercyL T Kurland

❮ Previous
Next ❯

Citations

Apr 15, 2000·Journal of Clinical Apheresis·R Weinstein
Mar 1, 1992·Annals of Neurology·D W AndersonD H Silberberg
Nov 1, 1992·Annals of Neurology·W M Landau
May 1, 1990·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·S F Marks, R W Millard
Sep 1, 1990·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·P D Larsen
Jan 1, 1990·New Directions for Mental Health Services·N G LaRocca, H L Hall
Mar 1, 1988·Journal of Neurology·H Meyer-Rienecker, F Buddenhagen
Dec 1, 1991·Journal of in Vitro Fertilization and Embryo Transfer : IVF·H MoriT Tamaya
Apr 21, 2009·Journal of Neurology·Mitchell T WallinJohn F Kurtzke
Feb 1, 1990·Journal of Steroid Biochemistry·A H Schuurs, H A Verheul
Apr 1, 1989·Journal of the Neurological Sciences·A Jennekens-SchinkelJ B Lanser
Jan 1, 1990·The Science of the Total Environment·G W Lowis
Sep 11, 1992·The Science of the Total Environment·G W Lowis
Jan 1, 1988·Social Science & Medicine·J M LabordeM L Teetzen
Nov 1, 2003·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·K K Zakzanis
Apr 10, 2003·Annals of Epidemiology·Ya-Ping JinHans Link
Jan 5, 2002·Archives of Environmental Health·R B SchifferC Copley
Oct 1, 1986·Journal of Clinical and Experimental Neuropsychology·S M Rao
Oct 13, 2007·Developmental Neuropsychology·William S MacAllisterLauren B Krupp
May 26, 2012·Brain : a Journal of Neurology·Mitchell T WallinUNKNOWN Veterans Affairs Multiple Sclerosis Centres of Excellence Epidemiology Group
Jan 1, 1995·Acta Neurologica Scandinavica. Supplementum·E GranieriM R Tola
Aug 15, 2008·Multiple Sclerosis : Clinical and Laboratory Research·R S PrakashA F Kramer
Aug 1, 1994·Journal of Periodontology·A F HeftiC Stone
Apr 3, 2010·Drugs & Aging·Amer Awad, Olaf Stüve
Dec 2, 2010·Women's Health·Céline JobinPierre Duquette
Sep 27, 2006·Journal of Women's Health·Dhelia M Williamson
Mar 1, 1987·Mayo Clinic Proceedings·J M StewartM Rodriguez
Jul 1, 1989·Mayo Clinic Proceedings·D R WynnL T Kurland
Apr 25, 2008·The Science of the Total Environment·Anthony Charles GregoryKaren E Gieseker
Feb 19, 2016·Neurology·Piyameth DilokthornsakulJonathan D Campbell
Apr 1, 1991·Urology·E Dula, G E Leach
Jan 1, 1984·Annals of the New York Academy of Sciences·N G LaRocca
Nov 1, 1984·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·N J HollandM G Madonna
Apr 17, 2015·Multiple Sclerosis and Related Disorders·Jonathan D CampbellKavita Nair
Apr 17, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Andrew J PalmerBruce V Taylor
Mar 3, 2007·American Journal of Epidemiology·Hollie SchmidtAllison Ashley-Koch
Apr 1, 1990·Medical Decision Making : an International Journal of the Society for Medical Decision Making·C MooneyC E Phelps

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.